Breast MRI as a radiomic biomarker of immune enrichment in HER2+breast cancer.

被引：0
|
作者：
Kennedy, Laura
Durenberger, Grace
Stanton, Sasha E.
Vinayak, Shaveta
Dintzis, Suzanne
Partridge, Savannah C.
Gadi, Vijayakrishna K.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Inst, Seattle, WA USA
[3] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14281
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Breast MRI as a radiomic biomarker of immune response in HER2+breast cancer
    Kennedy, Laura Carpin
    Durenberger, Grace
    Stanton, Sasha E.
    Vinayak, Shaveta
    Dintzis, Suzanne
    Partridge, Savannah
    Gadi, V. K.
    CANCER RESEARCH, 2020, 80 (04)
  • [2] Diffusion-weighted MRI as a possible biomarker of treatment response in a murine model of HER2+breast cancer.
    Whisenant, J. G.
    Xu, L.
    Gore, J. C.
    Yankeelov, T. E.
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (04) : 664 - 665
  • [3] Targeting glucose metabolism in HER2+breast cancer.
    Chang, Simone
    Chesney, Jason
    Trent, John O.
    Telang, Sucheta
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Safety of trastuzumab in women with HER2+breast cancer.
    Nowsheen, Somaira
    Aziz, Khaled
    Park, Jae Yoon
    Villarraga, Hector R.
    Herrmann, Joerg
    Ruddy, Kathryn Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Characterization of the immune infiltrate in HER2+breast cancer
    Ganesan, Shridar
    Alexe, Gabriela
    Hirshfield, Kim M.
    Yao, Ming
    Bhanot, Gyan
    Deborah, Toppmeyer
    CANCER RESEARCH, 2015, 75
  • [6] HER2+breast cancer
    Hicks, David G.
    Kulkarni, Swati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 263 - 273
  • [7] Genomics of HER2+breast cancer
    Perou, C.
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Impact of race on BluePrint genomic subtyping in HER2+breast cancer.
    Reid, Sonya A.
    Pal, Tuya
    Shu, Xiao-Ou
    Venton, Lindsay
    Whisenant, Jennifer G.
    Hoskins, Kent
    Dias, Eduardo
    Rahman, Rakhshanda Layeequr
    Wei, Jennifer
    Uygun, Sahra
    Singleton, Ciera S.
    Menicucci, Andrea
    Dauer, Patricia
    Audeh, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Impact of mastectomy in women with stage IV HER2+breast cancer.
    Babar, Arslan
    Covut, Fahrettin
    Kewan, Tariq Zuheir
    Rahman, Shafia
    Grobmeyer, Stephen R.
    Montero, Alberto J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Adjuvant and neoadjuvant trastuzumab in combination with vinorelbine for HER2+breast cancer.
    Esfahani, Khashayar
    Ferrario, Cristiano
    Le, Philippe
    Panasci, Lawrence C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345